Sign in
4

Changes in Ownership

Pelthos Therapeutics Inc. Filed Acc 0001753926-25-001175

Options or other derivatives

  • CEO and President acquired 338,678 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Plesha Scott M. CEO and President 2025-07-02 Grant or award · Restricted Stock Units +83,678 83,678 D: show line 1 in the form
Plesha Scott M. CEO and President 2025-07-02 Grant or award · Stock Option +255,000 255,000 D: show line 2 in the form
Loading xslF345X05/ownership.xml…